Understanding When Real World Data Can Be Used to Replicate A Clinical Trial: A Cross‐Sectional Study of Medications Approved in 2011 March 15, 2026
Reputation and Authority: The FDA and the Fight Over U.S. Prescription Drug Importation March 15, 2026
Incentivizing Antibiotic Development: Why Isn’t the Generating Antibiotic Incentives Now (GAIN) Act Working? March 15, 2026
Clinical Benefit and Cost of Breakthrough Cancer Drugs Approved By the US Food and Drug Administration March 15, 2026
Association Between FDA and EMA Expedited Approval Programs and Therapeutic Value of New Medicines: Retrospective Cohort Study March 15, 2026
Prescribing Systemic Steroids for Acute Respiratory Tract Infections in United States Outpatient Settings: A Nationwide Population-Based Cohort Study March 15, 2026
Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis March 15, 2026
Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications March 15, 2026
A Systematic Review and Meta-Analysis of Bevacizumab in First-Line Metastatic Breast Cancer: Lessons for Research and Regulatory Enterprises March 15, 2026